The division will offer pediatric and adult services, including immune effector, cell and gene therapies and graft engineering. A transplant and cell therapy and “good manufacturing practice” laboratory is under construction at the center.
“This is a tremendous opportunity to enable a continuum of care for pediatric and adult patients and extend the latest, state-of-the-art transplant, immune effector cell and gene therapy to patients in the Inland Empire and beyond,” stated Hisham Abdel-Azim, MD, the new division’s head of transplant and cell therapy and professor of pediatrics, medicine and basic sciences at Loma Linda.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
